RecruitingNCT05778006

Multi-Center Registry for ME/CFS

Multi-Center Registry for ME/CFS, Including ME/CFS Following Epstein-Barr Virus-Associated Infectious Mononucleosis (EBV-IM) or Coronavirus Disease 2019 (Covid-19)

Sponsor

Technical University of Munich

Enrollment

650 participants

Start Date

May 31, 2022

Study Type

OBSERVATIONAL

Conditions

ME/CFS CFS/ME ME/CFS Following EBV-associated Infectious Mononucleosis ME/CFS Following COVID-19

Summary

The ME/CFS study (MECFS-R) aims to create a large-scale registry that provides data on epidemiology, phenotypes, and disease trajectories of and health care for ME/CFS at any age in Germany, which can be used for future clinical trials.

Eligibility

Min Age: 0 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cfs/me, me/cfs, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 0 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

MRI Chronic Fatigue Center for Young People (MCFC) Children's Hospital, Technical University of Munich & Munich Municipal Hospital

Munich, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05778006

Related Trials

Patient-Centered Assessment of Symptoms and Outcomes

NCT039526241 location

Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS

NCT075291971 location

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

NCT048066201 location

OutreAch MediCal Care for HousEbound Patients With Post-COVID-19 Syndrome or ME/CFS of Any Cause (ACCESS)

NCT073522541 location

LIFT: Life Improvement Trial

NCT063667241 location